Literature DB >> 9178477

Immunity status against poliomyelitis in persons 13-14 years old living in Rome.

I Mastroeni1, A M Patti, A Fabrizi, A L Santi, A M Manduca, N Vescia, S Squarcione, G M Fara.   

Abstract

The immunity against poliomyelitis in 1000 subjects 13-14 years old was evaluated. Neutralizing antibodies against poliovirus type 1, 2 and 3 were detected in 97.6%, 95.8% and 70% of samples, respectively. 3/1000 (0.3%) subjects were simultaneously seronegative to the three types. WHO does not suggest a protective level of International Units (IU), but our data indicate that such level is 0.45 IU for polio type 1, 0.65 IU for the type 2 and 0.138 for the type 3. A booster dose of vaccine in adolescence to ensure personal and herd immunity is recommended.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178477     DOI: 10.1016/s0264-410x(96)00208-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

3.  Seroepidemiology of polioviruses among university students in northern Italy.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Silvia Cocchio; Roberta Lazzari; Elena Saracino; Chiara Bertoncello; Alessandra Buja; Andrea Trevisan
Journal:  Clin Vaccine Immunol       Date:  2012-06-27

4.  Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units.

Authors:  Sabine Diedrich; Hermann Claus; Eckart Schreier
Journal:  BMC Infect Dis       Date:  2002-02-06       Impact factor: 3.090

Review 5.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

6.  Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy).

Authors:  Silvio Tafuri; Rosa Prato; Domenico Martinelli; Agata Calvario; Anna Bozzi; Michele Labianca; Annamaria Patti; Pietro Luigi Lopalco; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2008-10-30       Impact factor: 3.090

7.  Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.

Authors:  Hai-Bo Wang; Shuang-Li Zhu; Jing-Shan Zheng; Ai-Li Gou; Hui Cui; Yong Zhang; Gui-Jun Ning; Chun-Xiang Fan; Yuan-Sheng Chen; Ke-Li Li; Ping Yuan; Chao Ma; Jing Ma; Hui Zheng; Xin-Chun Fan; Xin-Lan Li; Hai-Shu Tang; Xiao-Lei Li; Fan Zhang; Dong-Mei Yan; Dong-Yan Wang; Zhi-Qiang Cui; Li-Ping Ren; Hui Zhu; Hui-Ling Wang; Xiao-Hong Jiang; Hong-Qiu An; Yang Liu; Jing Li; Wen-Bo Xu; Ning Wen; Ai-Qiang Xu; Hui-Ming Luo
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.